These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2562036)
41. [Changes in T-lymphocyte response under the action of transfer factor in vivo]. Buc M; Siska P; Rovenský J; Pruzinec P; Stefanovic J; Pekárek J; Svejcar J Bratisl Lek Listy; 1982 Jul; 78(1):63-73. PubMed ID: 6751474 [No Abstract] [Full Text] [Related]
42. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Jones AL; Mowry BJ; Pender MP; Greer JM Immunol Cell Biol; 2005 Feb; 83(1):9-17. PubMed ID: 15661036 [TBL] [Abstract][Full Text] [Related]
43. Role of alpha1-adrenergic receptor antibodies in Alzheimer's disease. Karczewski P; Hempel P; Bimmler M Front Biosci (Landmark Ed); 2018 Jun; 23(11):2082-2089. PubMed ID: 29772547 [TBL] [Abstract][Full Text] [Related]
44. [Immunomodulating treatment of autoimmune diseases]. Bogdanikowa B Pol Arch Med Wewn; 1979 Aug; 62(2):103-11. PubMed ID: 388364 [No Abstract] [Full Text] [Related]
45. Is Alzheimer's disease an immunological disorder? Observations and speculations. Fudenberg HH; Whitten HD; Arnaud P; Khansari N Clin Immunol Immunopathol; 1984 Aug; 32(2):127-31. PubMed ID: 6610519 [No Abstract] [Full Text] [Related]
47. Transfer factor 1993: new frontiers. Fudenberg HH; Pizza G Prog Drug Res; 1994; 42():309-400. PubMed ID: 8085011 [No Abstract] [Full Text] [Related]
48. Treatment strategies for Alzheimer's disease. Bowen DM; Francis PT; Pangalos MN; Stephens PH; Procter AW Lancet; 1992 Jan; 339(8785):132-3. PubMed ID: 1345865 [No Abstract] [Full Text] [Related]
49. Humoral and cellular immunologic repertoire in Alzheimer's disease. Amaducci L; Falcini M; Lippi A Ann N Y Acad Sci; 1992 Nov; 663():349-56. PubMed ID: 1482064 [No Abstract] [Full Text] [Related]
50. Can immunotherapy treat neurodegeneration? Schwartz M Science; 2017 Jul; 357(6348):254-255. PubMed ID: 28729500 [No Abstract] [Full Text] [Related]
51. Making autoantibodies safe. Scanlan CN; Burton DR; Dwek RA Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4081-2. PubMed ID: 18344326 [No Abstract] [Full Text] [Related]
52. The Emerging Role of Innate Immunity in Alzheimer's Disease. Vijaya Kumar DK; Moir RD Neuropsychopharmacology; 2017 Jan; 42(1):362. PubMed ID: 27909333 [No Abstract] [Full Text] [Related]
56. [Immunological aspects of the treatment of various forms of Alzheimer's disease]. Leszek J; Kowal-Gierczak B Psychiatr Pol; 1989; 23(5-6):373-8. PubMed ID: 2562036 [No Abstract] [Full Text] [Related]
57. Detection of anti-cerebral autoantibodies in schizophrenia and Alzheimer's disease. Sugiura M; Yokoi Y; Maruyama S; Ishido T; Tokunaga Y; Sasaki K J Clin Lab Immunol; 1989 Jan; 28(1):1-3. PubMed ID: 2657070 [TBL] [Abstract][Full Text] [Related]
58. [Clinico-immunological study of psychoses in old age]. Shaposhnikov VS Vrach Delo; 1980 Jun; (6):96-8. PubMed ID: 7405183 [No Abstract] [Full Text] [Related]